Skip to content
Screener

Medline, Inc. MDLN Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number at other companies

UFP Technologies logo
UFP TechnologiesUFPT
$55.04K

Other financials

Income statement

See full
Revenue$7.7B+11.6%
Gross profit$2.2B+16.3%
Operating income$395.0M-38.5%
Net income$139.0M-57.8%
EPS (diluted)$0.07

Balance sheet

See full
Cash & equivalents$2.3B+299%
Total debt$12.6B
Total equity$11.6B
Total assets$39.4B

Cash flow

See full
Operating cash flow$715.0M+263%
CapEx$111.0M+0.9%
Free cash flow$604.0M+594%

Valuation

See full
Market cap$29.66B-4.6%
Enterprise value$39.95B
P/E33.4×
P/S

Profitability

See full
Gross margin27.5%+1.1pp
Operating margin8.7%+1.7pp
Net margin4.7%+1.8pp
FCF margin5.2%-0.6pp

Returns & leverage

See full
Return on equity7.8%
Debt / equity1.1×
Current ratio4.3×

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.

The source filing: Medline, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:48 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0002046386-26-000051
Line itemOptionsWtd. Avg. Grant Date Fair ValueWtd. Avg. Exercise PriceAverage Remaining Contractual Term(in years)Aggregate Intrinsic Value(in millions)
Outstanding as of December 31, 20256,770,442$11.97$29.00
Granted
Exercised(27,586)$12.40$29.00
Forfeited(156,452)$12.31$29.00
Outstanding as of June 27, 20266,586,404$11.96$29.009.5$65
Exercisable as of June 27, 20263,032,916$11.79$29.009.5$30
Expected to vest as of June 27, 20263,553,488$12.10$29.009.5$35

Item 1 - Financial Statements

FAQ

What is Medline, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number?
Medline, Inc. (MDLN) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number of $3.55M in Q2 2026.
What does share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number mean?
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Ask your AI about Medline, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude